Tag: incyte

October 7, 2019

BriaCell CEO: Incyte Collaboration Enabling New Clinical Trials for Breast Cancer Treatments

BriaCell Therapeutics CEO Dr. Bill Williams joined the Investing News Network to discuss his company's progress in developing an innovative...
February 7, 2019

FDA Delays Incyte’s Treatment for Graft-versus-host Disease

The original application decision was scheduled for February 24, but has been pushed back to May 24 by the US...
January 22, 2019

Incyte Announces First Patient Treated in Phase 3 Clinical Trial

Incyte (Nasdaq:INCY) today announced that the first patient has been treated in GRAVITAS-309, a pivotal Phase 3 trial for the...
December 17, 2018

Biotech Trends 2018: Immuno-oncology Disappoints

2018 marked another critical year of growth for the biotech market. Learn about key biotech trends before the new year...
September 13, 2018

Incyte Receives Positive Clinical Trial Results

Incyte released positive results from its Phase 2b clinical trial for a cream to alleviate symptoms of atopic dermatitis, a...